Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -31.26%174.04M | -36.51%525.61M | -50.14%253.17M | -43.33%827.92M | -28.59%507.74M | -4.29%1.46B | 60.68%711M | 5.75%1.53B | 100.54%442.48M | 69.41%1.44B |
| Operating income | -31.26%174.04M | -36.51%525.61M | -50.14%253.17M | -43.33%827.92M | -28.59%507.74M | -4.29%1.46B | 60.68%711M | 5.75%1.53B | 100.54%442.48M | 69.41%1.44B |
| Cost of sales | 30.00%-164.81M | 38.86%-490.2M | 42.16%-235.44M | 35.87%-801.8M | 30.87%-407.05M | -3.47%-1.25B | -56.86%-588.84M | 5.93%-1.21B | -61.96%-375.39M | -118.69%-1.28B |
| Operating expenses | 30.00%-164.81M | 38.86%-490.2M | 42.16%-235.44M | 35.87%-801.8M | 30.87%-407.05M | -3.47%-1.25B | -56.86%-588.84M | 5.93%-1.21B | -61.96%-375.39M | -118.69%-1.28B |
| Gross profit | -47.94%9.23M | 35.59%35.41M | -82.40%17.73M | -87.61%26.12M | -17.57%100.69M | -33.75%210.81M | 82.09%122.16M | 100.14%318.23M | 702.11%67.09M | -39.93%159M |
| Selling expenses | 39.52%-40.67M | 39.42%-100.17M | 14.85%-67.25M | -44.90%-165.35M | 8.99%-78.98M | -17.49%-114.11M | -45.86%-86.78M | -16.36%-97.13M | -3.79%-59.49M | 1.15%-83.47M |
| Administrative expenses | -16.10%-74.98M | 17.97%-128.94M | -5.96%-64.59M | -20.56%-157.19M | 30.22%-60.95M | -3.87%-130.38M | -24.22%-87.36M | -30.43%-125.53M | -10.07%-70.32M | -7.15%-96.24M |
| Impairment and provision | ---- | -77.30%-70.12M | ---- | -1,416.85%-39.55M | ---- | 110.61%3M | ---- | -2,582.65%-28.3M | ---- | -893.23%-1.06M |
| -Other impairment is provision | ---- | -77.30%-70.12M | ---- | -1,416.85%-39.55M | ---- | 110.61%3M | ---- | -2,582.65%-28.3M | ---- | -893.23%-1.06M |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | -59.46%-72.58M | -296.94%-123.53M | -540.95%-45.52M | -91.17%-31.12M |
| Special items of operating profit | -24.04%21.65M | -72.56%20.19M | 15.57%28.51M | 41.25%73.57M | -40.95%24.67M | -72.16%52.09M | 94.42%41.77M | -82.99%187.09M | 123.75%21.48M | 3,035.01%1.1B |
| Operating profit | 0.97%-84.78M | 7.16%-243.62M | -487.37%-85.6M | -1,325.77%-262.4M | 82.40%-14.57M | -83.64%21.41M | 4.59%-82.79M | -87.50%130.82M | 33.18%-86.77M | 856.98%1.05B |
| Financing cost | -34.71%-104.98M | -18.65%-171.66M | -7.98%-77.93M | -20.76%-144.67M | ---72.17M | ---119.8M | ---- | ---- | ---- | ---- |
| Share of profits of associates | -798.47%-92.55M | -35.27%-16.3M | 18.97%13.25M | -686.56%-12.05M | 201.27%11.14M | 115.87%2.05M | 802.85%3.7M | -105.74%-12.95M | 74.78%-526K | -1,005.80%-6.29M |
| Earning before tax | -87.85%-282.31M | -2.97%-431.57M | -98.77%-150.28M | -335.07%-419.12M | 4.40%-75.61M | -181.72%-96.33M | 9.40%-79.09M | -88.67%117.88M | 33.84%-87.29M | 903.12%1.04B |
| Tax | 9,377.47%17.25M | 151.21%83.27M | --182K | -69.01%33.15M | ---- | 461.69%106.97M | ---178K | 91.15%-29.58M | ---- | -815.16%-334.22M |
| After-tax profit from continuing operations | -76.59%-265.06M | 9.76%-348.31M | -98.53%-150.1M | -3,727.55%-385.97M | 4.62%-75.61M | -87.95%10.64M | 9.19%-79.27M | -87.50%88.3M | 33.84%-87.29M | 950.93%706.14M |
| Earning after tax | -76.59%-265.06M | 9.76%-348.31M | -98.53%-150.1M | -3,727.55%-385.97M | 4.62%-75.61M | -87.95%10.64M | 9.19%-79.27M | -87.50%88.3M | 33.84%-87.29M | 950.93%706.14M |
| Minority profit | 243.02%3.52M | -213.75%-13.92M | -0.08%-2.46M | -174.33%-4.44M | 55.12%-2.46M | -47.67%5.97M | -36.71%-5.49M | 231.95%11.4M | -520.25%-4.01M | -304.98%-8.64M |
| Profit attributable to shareholders | -81.92%-268.59M | 12.36%-334.39M | -101.84%-147.64M | -8,264.69%-381.54M | 0.86%-73.15M | -93.92%4.67M | 11.41%-73.78M | -89.24%76.9M | 36.57%-83.28M | 1,035.00%714.78M |
| Basic earnings per share | -81.88%-0.1084 | 12.11%-0.135 | -102.72%-0.0596 | -8,184.21%-0.1536 | 1.01%-0.0294 | -93.67%0.0019 | 7.48%-0.0297 | -89.09%0.03 | 36.44%-0.0321 | 904.01%0.2751 |
| Diluted earnings per share | -81.88%-0.1084 | 12.11%-0.135 | -0.0596 | -8,184.21%-0.1536 | -93.67%0.0019 | -89.09%0.03 | 904.01%0.2751 | |||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.